{{Drugbox
| drug_name = 
| IUPAC_name        = ''N''-(4-Ethoxyphenyl)-3-hydroxybutanamide
| image             = Bucetin.svg
| alt               = 
| caption           = 

<!-- Clinical data -->
| tradename         = 
| Drugs.com         = 
| MedlinePlus       = 
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      = <!-- A / B            / C / D / X -->
| pregnancy_category= 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status      = 
| routes_of_administration = 

<!-- Pharmacokinetic data -->
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 
| excretion         = 

<!-- Identifiers -->

| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 1083-57-4
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6M7CVQ8PF8
| ATCvet            = 
| ATC_prefix        = N02
| ATC_suffix        = BE04
| PubChem           = 14130
| ChEMBL = 1697856
| DrugBank          = 
| ChemSpiderID      = 13507

<!-- Chemical data -->
| C=12 | H=17 | N=1 | O=3
| molecular_weight  = 223.268 g/mol
| smiles            = O=C(Nc1ccc(OCC)cc1)CC(O)C
| StdInChI          = 1S/C12H17NO3/c1-3-16-11-6-4-10(5-7-11)13-12(15)8-9(2)14/h4-7,9,14H,3,8H2,1-2H3,(H,13,15)
| StdInChIKey       = LIAWQASKBFCRNR-UHFFFAOYSA-N
}}

'''Bucetin''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]) is an [[analgesic]] and [[antipyretic]] that is no longer marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA184|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=184–}}</ref><ref>{{cite web | url=http://www.whocc.no/atc_ddd_index/?code=N02BE04&showdescription=yes | title=WHOCC - ATC/DDD Index | date=December 19, 2013 | publisher=WHO Collaborating Centre for Drug Statistics Methodology }}</ref>  Chemically, it is similar to [[phenacetin]] with which it shares the risk of [[carcinogenesis]].<ref>{{cite journal | pmid = 3479641 | year = 1987 | last1 = Togei | first1 = K | last2 = Sano | first2 = N | last3 = Maeda | first3 = T | last4 = Shibata | first4 = M | last5 = Otsuka | first5 = H | title = Carcinogenicity of bucetin in (C57BL/6 X C3H)F1 mice | volume = 79 | issue = 5 | pages = 1151–8 | journal = Journal of the National Cancer Institute | doi=10.1093/jnci/79.5.1151 }}{{closed access}}</ref>  Bucetin was withdrawn from use in 1986 due to renal toxicity.<ref>{{Cite journal | journal = Drug Information Journal | volume = 35 | pages = 293–317 | year = 2001 | doi = 10.1177/009286150103500134 | title = Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999 | last1 = Fung | first1 = M. | last2 = Thornton | first2 = A. | last3 = Mybeck | first3 = K. | last4 = Wu | first4 = J. H.-h. | last5 = Hornbuckle | first5 = K. | last6 = Muniz | first6 = E. }}{{closed access}}</ref>

==See also==
* [[List of withdrawn drugs]]

==References==
{{Reflist|2}}

{{Anti-inflammatory products}}
{{Prostanoidergics}}
{{Wiktionary}}

[[Category:Analgesics]]
[[Category:Antipyretics]]
[[Category:Anilides]]
[[Category:Withdrawn drugs]]


{{analgesic-stub}}